Sector:
Healthcare

Location:
Cambridge, MA

Year Funded:
1998

Status:
IPO/Acquired by Millennium Pharmaceuticals

Summary:
LeukoSite developed drugs to block disease promoting actions of white blood cells, with potential applications within the areas of cancer, autoimmune and viral diseases.